LD-2 disclosure · 2nd Quarter - Report
PHILIPS HOLDING USA INC.
via PHILIPS HOLDING USA, INC.
Client
- Name
- PHILIPS HOLDING USA INC.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- PHILIPS HOLDING USA, INC.
- Description
- Manufacturing
- Location
- Cambridge, Massachusetts, United States of America
Lobbying activities
8 issuesMedicare/Medicaid
HR 1691, Ensuring Patient Access to Critical Breakthrough Products Act; transitional coverage for emerging technologies (TCET) proposal Site neutrality payment proposals under Medicare Medicare Physician Fee Schedule reform H.R.7623, Telehealth Modernization Act, all provisions Medicare pathway to reimbursement for FDA-cleared Algorithm-Based Health Care Services/AI
LobbyistsMONICA VOLANTE · ELIZABETH PIKA SHARP
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
3rd Party Service regulation Cybersecurity Right to Repair of medical devices Artificial Intelligence and medical devices Mandatory device shortage reporting proposals EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof HR. 8818, American Privacy Rights Act of 2024 - Title I
LobbyistsMONICA VOLANTE · ELIZABETH PIKA SHARP
TargetedSENATE · HOUSE OF REPRESENTATIVES · Vice President of the U.S. · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Budget/Appropriations
FY 2024 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2024 Defense Department Appropriations 2024 National Defense Authorization Act including issues related to RATE and low helium MRIs